MDMA modifies active avoidance learning and recall in mice

José Manuel Trigo1, Araceli Cabrero-Castel, Fernando Berrendero

  • 1Laboratori de Neurofarmacologia, Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain.

Psychopharmacology
|January 11, 2008
PubMed
Abstract

Insights

3,4-methylenedioxymethamphetamine (MDMA) impairs learning and memory in mice. Acute MDMA disrupts task acquisition and recall, while repeated high doses reduce learning and memory performance, affecting dopamine transporter binding.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Cognitive Science

Background:

  • Studies suggest cognitive deficits following 3,4-methylenedioxymethamphetamine (MDMA) exposure.
  • The precise impact of MDMA on learning and memory remains incompletely understood.

Purpose of the Study:

  • To investigate the effects of various MDMA dosing regimens on active avoidance learning and recall in mice.
  • To assess the impact of MDMA on dopamine transporter (DAT) binding.

Main Methods:

  • Mice received acute or repeated MDMA doses (0-30 mg/kg) under different experimental conditions.
  • Active avoidance acquisition and recall were evaluated.
  • Dopamine transporter (DAT) binding was assessed post-MDMA administration.

Main Results:

  • Acute MDMA administration before training impaired active avoidance acquisition and recall.
  • Repeated high-dose MDMA before training reduced acquisition, while pre-treatment with high and low doses impaired recall.
  • Reduced DAT binding was observed 4 days, but not 23 days, after the last MDMA dose.

Conclusions:

  • Acute MDMA administration affects active avoidance learning and performance in mice.
  • Repeated MDMA pre-treatment significantly impairs both the acquisition and recall of active avoidance tasks.
  • MDMA-induced changes in DAT binding are transient.

Related Concept Videos